D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma - ScienceDirect
SciELO - Brasil - D2-40, a novel lymphatic endothelial marker: identification of lymphovascular invasion and relationship with axillary metastases in breast cancer D2-40, a novel lymphatic endothelial marker: identification of lymphovascular invasion
Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix | Modern Pathology
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
Články a aktuality: Články a aktuality 2012 - 2018
Cureus | Prognostic Significance of Lymphovascular Invasion Detected by D2- 40 in Low-Risk Stage II Colon Cancer | Article